0001653477-19-000093.txt : 20190429 0001653477-19-000093.hdr.sgml : 20190429 20190429115141 ACCESSION NUMBER: 0001653477-19-000093 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190425 FILED AS OF DATE: 20190429 DATE AS OF CHANGE: 20190429 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NARWOLD KAREN G CENTRAL INDEX KEY: 0001095670 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37586 FILM NUMBER: 19774616 MAIL ADDRESS: STREET 1: ALBEMARLE CORPORATION STREET 2: 451 FLORIDA STREET CITY: BATON ROUGE STATE: LA ZIP: 707801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ingevity Corp CENTRAL INDEX KEY: 0001653477 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] IRS NUMBER: 474027764 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5255 VIRGINIA AVENUE CITY: NORTH CHARLESTON STATE: SC ZIP: 29406 BUSINESS PHONE: 8437402300 MAIL ADDRESS: STREET 1: 5255 VIRGINIA AVENUE CITY: NORTH CHARLESTON STATE: SC ZIP: 29406 4 1 wf-form4_155655308663461.xml FORM 4 X0306 4 2019-04-25 0 0001653477 Ingevity Corp NGVT 0001095670 NARWOLD KAREN G 5255 VIRGINIA AVENUE NORTH CHARLESTON SC 29406 1 0 0 0 Common Stock 2019-04-25 4 A 0 845 0 A 1052 D Represents a grant of deferred stock units, pursuant to the Reporting Person's election, in lieu of such Reporting Person's annual award grant of restricted stock units. These deferred stock units will be settled into an equal number of shares of common stock following the Reporting Person's termination of board service under the Non-Employee Director Deferred Compensation Plan and pursuant to the 2016 Omnibus Incentive Plan. These shares will all vest on April 25, 2020. /s/ Karen G. Narwold by Katherine P. Burgeson as Attorney-in-Fact 2019-04-29 EX-24 2 ex-24.htm NARWOLD POA
POWER OF ATTORNEY

Know by all these present, that the undersigned, Karen G. Narwold, having a business address of 5255 Virginia Ave, North Charleston, SC 29406 and a telephone number of 843-740-2300, hereby constitutes and appoints Katherine P. Burgeson, Ryan C. Fisher, or Kelly R. Snipes as representatives of Ingevity Corporation, as the undersigned's true and lawful attorney-in-fact for the following limited purposes:

1) to file for and on behalf of the undersigned, in the undersigned's capacity as a Director of Ingevity Corporation (the "Company"), the SEC's Form ID Application in order to obtain EDGAR filing codes in addition to filing the Forms 3, 4, and 5 from time to time, in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

2) to do and perform any and all acts for an on behalf of the undersigned that may be necessary or desirable to complete and execute any such Application on Form ID, Form 3, 4, or 5 and file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

3) to take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion, and limited to filings required under Section 16(a) of the Securities Exchange Act of 1934.

The undersigned hereby grants to such attorney-in-fact limited power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 30th day of January 2019.

Signature: /s/ Karen G. Narwold

Name/Title/Position with Company:
Karen G. Narwold, Director